Pediatrician ADHD Media Support Package for Parents

描述(由申请人提供)：患有ADHD的儿童有很大的风险无法完成高中学业，多达25%的儿童会患上慢性病 持续到成年的反社会行为模式。初级保健 提供者--评估和治疗绝大多数 患有ADHD的儿童--通常不能系统地和经验性地使用 指导他们评估和治疗决定的程序。的目标是 建议的研究是评估使用媒体支持包的可行性 帮助以社区为基础的儿科医生实施经验证的 干预技术。考虑到有限的时间，医生(和其他健康 护理专业人员)可以提供给每个家庭，这些工具对于 知情的患者家庭和有效的临床实践--而不是 目前是存在的。三个主要内容领域是：1)诊断和 评估；2)滴定试验；3)药物维护。在第一阶段，所有 将设计三个组件，第二个组件将作为 录像带原型。第二阶段将以视频形式制作其余部分，并 将内容改编为Web增强型CD-ROM。评估将是 分两个阶段进行：(1)在设计过程中进行形成性评估 如专家和最终用户对以下几个阶段的评审所代表的 原型和(2)涉及其传播的材料的实地试验 在一项由NIMH资助的疗效研究中，对大约100名患者家属进行了调查 以大学为基础的辅助基础设施，用于支持 照顾ADHD儿童，措施包括情感、认知和 行为指数：(1)家长和儿科医生对产品的看法 有用性和可用性，(2)产品培养的家长理解力和 (3)家长和儿科医生对有效的临床实践的依从性。 建议的商业应用： 拟议中的媒体助手的潜在市场相当大。它们将被各种医疗保健提供者使用，包括精神科医生、儿科医生和家庭医生，所有这些人都为ADHD儿童提供护理。仅在儿科医生中，今天美国就有大约30,000名执业儿科医生。目前，医疗服务提供者将被鼓励购买至少一盘录像带，用于他们在美国的办公实践。将鼓励卫生服务提供者购买至少一盘录像带用于他们的办公室实践，可以在办公室向父母展示，或者允许父母在空闲时将录像带带回家观看，以便以后归还。与录像带配套的小册子将由卫生从业者批量购买，分发给父母/由父母购买。对父母的直销代表着一个额外的市场。 几家制药公司正在以一种便于滴定方法的方式包装ADHD药物。一旦制药公司完成包装，他们将使用自己的代表、广告和信件向医疗保健提供者推销他们的产品。目前提议的媒体支持包将向这些制药公司销售或与其新包装的药物一起包装。这种兴趣在本申请中有记录。

DESCRIPTION (provided by applicant): Children with ADHD are at significant risk for failing to complete high school and as many as 25 percent develop chronic patterns of antisocial behavior that persist into adulthood. Primary care providers--the practitioners who evaluate and treat the vast majority of children with ADHD--often fail to utilize systematic and empirically based procedures to guide their evaluation and treatment decisions. The goal of the proposed research is to assess the feasibility of using a media support package to aid community-based pediatricians in their implementation of proven intervention techniques. Given the limited time physicians (and other health care professionals) can provide to each family, such tools are essential for informed patient families and effective clinical practice -- and do not presently exist. The three primary content areas are: 1) Diagnosis and Assessment; 2) Titration Trials; and 3) Medication Maintenance. In phase I, all three components will be designed and the second will be fully produced as a videotape prototype. Phase II will produce the remaining sections as video and adapt the content for delivery as a web-enhanced CD-ROM. Evaluation will be conducted in two stages: (1) formative evaluation throughout the design process as represented by expert and end-user reviews of several stages of the prototype and (2) a field-trial of the materials involving their dissemination to approximately 100 patient-families in an NIMH-funded study of the efficacy of a university-based assistive infrastructure for supporting pediatricians in caring for children with ADHD, Measures include affective, cognitive and behavioral indices: (1) parent and pediatrician perceptions of the product's usefulness and usability, (2) parent comprehension fostered by the product and (3) parent and pediatrician compliance with effective clinical practice. PROPOSED COMMERCIAL APPLICATION: The potential market for the proposed set of media aides is quite large. They will be used by a variety of health care providers, including psychiatrists, pediatricians, and family practitioners, all of whomprovide care for ADHD children. Among pediatricians alone, there are approximately 30,000 practicing pediatricians in the U.S. today. Health providers will be encouraged to purchase at least one videotape for their office practice in the U.S. today. Health provider will be encouraged to purchase at least one videotape for their office practice which could be shown to parents either in the office or parents could be allowed to take the videotapes home to view it at their leisure to be returned at a later date. The booklets that accompany the videotapes will be purchased in bulk by the health practitioners to be given to/purchased by parents. Direct sales to parents represents an additional market. Several pharmaceutical companies are in the process of packaging ADHD medications in such a way that facilitates titration methodology. Once packaging is completed by the pharmaceutical companies, they will then market their product using their own representatives, advertising, and letters to health care providers. The currently proposed media support package will be marketed to these pharmaceutical companies to be sold or packaged with their newly packaged medications. Such interest is documented in this application.